𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant interferon-α-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study

✍ Scribed by Y. Imai; S. Kawata; S. Tamura; N. Ito; K. Seki; M. Nishiuchi; Y. Shinji; K. Kiriyama; S. Himeno; Y. Minami; T. Kashihara; F. Kawakami; H. Maeda; I. Yabuuchi; M. Nishioka; Y. Shirai; K. Fukuda; S. Kiso; T. Ito; M. Igura; Y. Doi; Y. Matsuzawa

Book ID
111250078
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
515 KB
Volume
17
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C with re
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial
✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels

A multicenter randomized controlled dose
A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C
✍ Susumu Takano; Yoshimi Ito; Osamu Yokosuka; Masao Ohto; Katsuo Uchiumi; Katsutar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

## AND MASAO OMATA~ The effect of ursodeoxycholic acid on liver function tests and on bile acid metabolism was investigated in a multi-center randomized controlled dose study for chronic hepatitis C. Twenty, 18 and 19 patients were administered 150, 600 and 900 mglday, respectively of ursodeoxycho

High doses of recombinant α-interferon o
High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial
✍ Federico Sáez-royuela; Juan Carlos Porres; Alberto Moreno; Inmaculada Castillo; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten

Treatment of chronic hepatitis C with co
Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial
✍ M J Tong; K R Reddy; W M Lee; P J Pockros; J C Hoefs; E B Keeffe; F B Hollinger; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

AND THE CONSENSUS INTERFERON STUDY GROUP 15 tion. Efficacy was assessed by normalization of serum alanine This multicenter, randomized, controlled, double-blind, transaminase (ALT) concentration and decrease in serum hepphase III study in 704 patients with chronic hepatitis C infecatitis C virus (HC